Context Medical therapy for Cushing syndrome (CS) typically aims to reduce daily cortisol output without addressing circadian rhythm restoration. No licensed drugs target this goal. Objective We investigated the efficacy and safety of timed, once-daily osilodrostat administration in improving cir…